Media Summary: In this HealthTree video, we break down the difference between Niels van de Donk, MD, PhD, VU University Medical Center, Amsterdam, Netherlands, discusses the downregulation of B-cell ... Some of the treatments that we give here at Roswell include

Blood Cancer Research Targeted Therapy In Multiple Myeloma - Detailed Analysis & Overview

In this HealthTree video, we break down the difference between Niels van de Donk, MD, PhD, VU University Medical Center, Amsterdam, Netherlands, discusses the downregulation of B-cell ... Some of the treatments that we give here at Roswell include Dr. Philip Greenberg discusses how immunotherapy works for UCLA hematologist and oncologist Sarah M. Larson, MD discusses the current and new ways of treating Oncologists discuss leading and emerging treatment options for patients with

Bruno Paiva, Pharm.D., Ph.D., Scientific Coordinator of the Diagnostic Laboratories of the University of Navarra in Spain, is an ... In this episode, Suzanne Lentzsch, MD, Ph.D., and Joseph Mikhael, MD, MEd, FRCPC, FACP, discuss the role of BCMA-

Photo Gallery

Blood Cancer Research: Targeted therapy in multiple myeloma
Blood Cancer Research: CAR-T in Multiple Myeloma
What are the Side Effects of Targeted Therapies for Multiple Myeloma? | Norton Cancer Institute
Targeted Therapy vs Immunotherapy in Myeloma: What’s the Difference?
Treating multiple myeloma resistant to BCMA-targeted therapy
Multiple Myeloma I Blood Cancer I Treatment I Targeted therapy I Immunotherapy
Niamh Murray and Prof. Ann Hopkins in conversation about Multiple Myeloma (a type of blood cancer)
What is the Best Treatment for Multiple Myeloma?
Myeloma Treatments Explained: Targeted vs. Traditional Chemotherapy
Leukemia, Lymphoma, Myeloma, and Immunotherapy with Dr. Philip Greenberg
Novel Therapies for Multiple Myeloma | Closer to a Cure Community Lecture Series
BCMA-Targeted Therapies in Multiple Myeloma
Sponsored
Sponsored
View Detailed Profile
Blood Cancer Research: Targeted therapy in multiple myeloma

Blood Cancer Research: Targeted therapy in multiple myeloma

Dana-Farber

Blood Cancer Research: CAR-T in Multiple Myeloma

Blood Cancer Research: CAR-T in Multiple Myeloma

Dana-Farber

Sponsored
What are the Side Effects of Targeted Therapies for Multiple Myeloma? | Norton Cancer Institute

What are the Side Effects of Targeted Therapies for Multiple Myeloma? | Norton Cancer Institute

Dr. Don A. Stevens, M.D., at Norton

Targeted Therapy vs Immunotherapy in Myeloma: What’s the Difference?

Targeted Therapy vs Immunotherapy in Myeloma: What’s the Difference?

In this HealthTree video, we break down the difference between

Treating multiple myeloma resistant to BCMA-targeted therapy

Treating multiple myeloma resistant to BCMA-targeted therapy

Niels van de Donk, MD, PhD, VU University Medical Center, Amsterdam, Netherlands, discusses the downregulation of B-cell ...

Sponsored
Multiple Myeloma I Blood Cancer I Treatment I Targeted therapy I Immunotherapy

Multiple Myeloma I Blood Cancer I Treatment I Targeted therapy I Immunotherapy

Myeloma, also called

Niamh Murray and Prof. Ann Hopkins in conversation about Multiple Myeloma (a type of blood cancer)

Niamh Murray and Prof. Ann Hopkins in conversation about Multiple Myeloma (a type of blood cancer)

As part of our '

What is the Best Treatment for Multiple Myeloma?

What is the Best Treatment for Multiple Myeloma?

Some of the treatments that we give here at Roswell include

Myeloma Treatments Explained: Targeted vs. Traditional Chemotherapy

Myeloma Treatments Explained: Targeted vs. Traditional Chemotherapy

Confused about the difference between

Leukemia, Lymphoma, Myeloma, and Immunotherapy with Dr. Philip Greenberg

Leukemia, Lymphoma, Myeloma, and Immunotherapy with Dr. Philip Greenberg

Dr. Philip Greenberg discusses how immunotherapy works for

Novel Therapies for Multiple Myeloma | Closer to a Cure Community Lecture Series

Novel Therapies for Multiple Myeloma | Closer to a Cure Community Lecture Series

UCLA hematologist and oncologist Sarah M. Larson, MD discusses the current and new ways of treating

BCMA-Targeted Therapies in Multiple Myeloma

BCMA-Targeted Therapies in Multiple Myeloma

Review of BCMA-

BCMA-targeted Therapies and Multiple Myeloma

BCMA-targeted Therapies and Multiple Myeloma

Peter Voorhees, MD of the Levine

Advances in Blood Cancer Treatments

Advances in Blood Cancer Treatments

Um thank you for that going back to the

Treatments for Patients with Triple Class Refractory Multiple Myeloma - Blood Cancers Video Library

Treatments for Patients with Triple Class Refractory Multiple Myeloma - Blood Cancers Video Library

Oncologists discuss leading and emerging treatment options for patients with

New immunotherapy for multiple myeloma shows promising results

New immunotherapy for multiple myeloma shows promising results

A breakthrough in

What is myeloma?

What is myeloma?

Dr. Ken Anderson, leading researcher of

Dr. Bruno Paiva on Multiple Myeloma

Dr. Bruno Paiva on Multiple Myeloma

Bruno Paiva, Pharm.D., Ph.D., Scientific Coordinator of the Diagnostic Laboratories of the University of Navarra in Spain, is an ...

Optimizing bridging therapy prior to CAR T-cell therapy in multiple myeloma

Optimizing bridging therapy prior to CAR T-cell therapy in multiple myeloma

Doris Hansen, MD, Moffitt

Practical Insights on Using BCMA-Targeted Therapies in Multiple Myeloma

Practical Insights on Using BCMA-Targeted Therapies in Multiple Myeloma

In this episode, Suzanne Lentzsch, MD, Ph.D., and Joseph Mikhael, MD, MEd, FRCPC, FACP, discuss the role of BCMA-